Clinical trial
D-serine Adjuvant Treatment for Parkinson's Disease
NCT00215904 · Herzog Hospital, Other · Completed
Key facts
| NCT number | NCT00215904 |
|---|---|
| Title | D-serine Adjuvant Treatment for Parkinson's Disease |
| Official title | D-serine Adjuvant Treatment for Parkinson's Disease |
| Lead sponsor | Herzog Hospital, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Parkinson's Disease |
| Intervention type | Drug |
| Interventions | D-serine (~2g/day) |
| Enrollment | 13 |
| Start date | Aug 1, 2003 |
| Primary completion | May 1, 2008 |
| Completion | May 1, 2008 |
| First posted | Sep 22, 2005 |
| Last update posted | Jul 9, 2012 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: